Case Name (Date)

Petros et al. v. Rahal Biosciences, Inc.
24-cv-3182, S.D.N.Y.
(April 2024)


Product/Service

ARMRA Colostrum dietary supplements


Allegations

Falsely marketing products as “research-backed” to provide various health benefits – including “strengthen[ing] immunity,” “fortify[ing] gut health,” and “activat[ing] hair growth” – without adequate scientific evidence to support such claims

Failing to include mandated disclaimers with disease treatment claims, in violation of FDA regulations


Status

Voluntarily dismissed When a complaint is dismissed with prejudice, it cannot be refiled.



The Latest

Filters

Stellantis Steers Away from Deceptive Made in USA Claims

Press Release

Stellantis Steers Away from Deceptive Made in USA Claims

MADISON, CONN. April 9, 2025 — Dutch automaker Stellantis has paused its new “American Born” campaign after getting called out by consumer advocacy organization truthinadvertising.org (TINA.org). Released in the wake…


Show More